Anticonvulsants and anxiolytics: Barbiturates

Anticonvulsants and anxiolytics: Barbiturates

General Med

General Med

Fever of unknown origin: Clinical
Headaches: Clinical
Cluster headache
Tension headache
Migraine medications
Migraine
Headaches: Pathology review
Fat-soluble vitamin deficiency and toxicity: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Zinc deficiency and protein-energy malnutrition: Pathology review
Antihistamines for allergies
Glucocorticoids
Coronary artery disease: Clinical
Coronary artery disease: Pathology review
Heart failure: Clinical
Heart failure: Pathology review
Syncope: Clinical
Hypertension: Clinical
Hypercholesterolemia: Clinical
Peripheral vascular disease: Clinical
Leg ulcers: Clinical
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Adrenergic antagonists: Presynaptic
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Calcium channel blockers
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Antiplatelet medications
Hypersensitivity skin reactions: Clinical
Eczematous rashes: Clinical
Papulosquamous skin disorders: Clinical
Papulosquamous and inflammatory skin disorders: Pathology review
Alopecia: Clinical
Hypopigmentation skin disorders: Clinical
Benign hyperpigmented skin lesions: Clinical
Skin cancer: Clinical
Diabetes mellitus: Clinical
Diabetes mellitus: Pathology review
Hyperthyroidism: Clinical
Hyperthyroidism: Pathology review
Hypothyroidism and thyroiditis: Clinical
Hypothyroidism: Pathology review
Dizziness and vertigo: Clinical
Hyperthyroidism medications
Hypothyroidism medications
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Gastroesophageal reflux disease (GERD): Clinical
Peptic ulcers and stomach cancer: Clinical
Diarrhea: Clinical
Malabsorption: Clinical
Colorectal cancer
Diverticular disease: Clinical
Diverticular disease: Pathology review
Anal conditions: Clinical
Cirrhosis: Clinical
Cirrhosis: Pathology review
Breast cancer: Clinical
Breast cancer: Pathology review
Laxatives and cathartics
Antidiarrheals
Acid reducing medications
Anemia: Clinical
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Pneumonia: Clinical
Pneumonia: Pathology review
Urinary tract infections: Clinical
Urinary tract infections: Pathology review
Skin and soft tissue infections: Clinical
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Anti-mite and louse medications
Chronic kidney disease: Clinical
Kidney stones: Clinical
Urinary incontinence: Pathology review
PDE5 inhibitors
Stroke: Clinical
Lower back pain: Clinical
Back pain: Pathology review
Asthma: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Obstructive lung diseases: Pathology review
Lung cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Allergic rhinitis
Pediatric allergies: Clinical
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Joint pain: Clinical
Rheumatoid arthritis
Rheumatoid arthritis: Clinical
Rheumatoid arthritis and osteoarthritis: Pathology review
Septic arthritis
Reactive arthritis
Psoriatic arthritis
Anatomy clinical correlates: Heart
Anatomy clinical correlates: Axilla
Anatomy clinical correlates: Breast
Anatomy clinical correlates: Mediastinum
Anatomy clinical correlates: Thoracic wall
Anatomy clinical correlates: Wrist and hand
Anatomy clinical correlates: Vertebral canal
Anatomy clinical correlates: Pleura and lungs
Anatomy clinical correlates: Other abdominal organs
Anatomy clinical correlates: Spinal cord pathways
Anatomy clinical correlates: Male pelvis and perineum
Anatomy clinical correlates: Peritoneum and diaphragm
Anatomy clinical correlates: Female pelvis and perineum
Anatomy clinical correlates: Arm, elbow and forearm
Anatomy clinical correlates: Clavicle and shoulder
Anatomy clinical correlates: Viscera of the gastrointestinal tract
Anatomy clinical correlates: Median, ulnar and radial nerves
Anatomy clinical correlates: Anterior and posterior abdominal wall
Anatomy clinical correlates: Bones, joints and muscles of the back
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid agonists, mixed agonist-antagonists and partial agonists
Antigout medications
Osteoporosis medications
Osteoporosis
Bone disorders: Pathology review
Pregnancy
Ectopic pregnancy
Complications during pregnancy: Pathology review
Hypertensive disorders of pregnancy: Clinical
Perinatal infections: Clinical
Abnormal uterine bleeding: Clinical
Antepartum hemorrhage: Clinical
Abdominal pain: Clinical
Routine prenatal care: Clinical
Stages of labor
Amenorrhea
Amenorrhea: Clinical
Amenorrhea: Pathology review
Contraception: Clinical
Virilization: Clinical
Infertility: Clinical
Vulvovaginitis: Clinical
Sexually transmitted infections: Clinical
Menopause
Abnormal labor: Clinical
Uterine disorders: Pathology review
Irritable bowel syndrome
Cervical cancer: Clinical
Estrogens and antiestrogens
Progestins and antiprogestins
Androgens and antiandrogens
Congenital heart defects: Clinical
Cyanotic congenital heart defects: Pathology review
Acyanotic congenital heart defects: Pathology review
Pediatric ear, nose, and throat conditions: Clinical
Pediatric constipation: Clinical
Pediatric gastrointestinal bleeding: Clinical
Pediatric vomiting: Clinical
Developmental milestones: Clinical
Developmental dysplasia of the hip
Developmental and learning disorders: Pathology review
Puberty and Tanner staging
Precocious and delayed puberty: Clinical
Child abuse: Clinical
Viral exanthems of childhood: Pathology review
Vaccinations: Clinical
Pediatric infectious rashes: Clinical
Pediatric bone and joint infections: Clinical
Pediatric urological conditions: Clinical
Elimination disorders: Clinical
Neurodevelopmental disorders: Clinical
Pediatric ophthalmological conditions: Clinical
Pediatric bone tumors: Clinical
Pediatric orthopedic conditions: Clinical
Pediatric lower airway conditions: Clinical
Pediatric upper airway conditions: Clinical
BRUE, ALTE, and SIDS: Clinical
Pediatric brain tumors
Mood disorders: Clinical
Mood disorders: Pathology review
Anxiety disorders: Clinical
Anxiety disorders, phobias and stress-related disorders: Pathology Review
Eating disorders: Clinical
Eating disorders: Pathology review
Obsessive compulsive disorders: Clinical
Personality disorders: Clinical
Sleep disorders: Clinical
Substance misuse and addiction: Clinical
Drug misuse, intoxication and withdrawal: Alcohol: Pathology review
Drug misuse, intoxication and withdrawal: Hallucinogens: Pathology review
Drug misuse, intoxication and withdrawal: Stimulants: Pathology review
Somatic symptom disorders: Clinical
Sexual dysfunctions: Clinical
Selective serotonin reuptake inhibitors
Serotonin syndrome
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Atypical antidepressants
Monoamine oxidase inhibitors
Atypical antipsychotics
Typical antipsychotics
Anticonvulsants and anxiolytics: Benzodiazepines
Anticonvulsants and anxiolytics: Barbiturates
Seizures: Clinical
Nonbenzodiazepine anticonvulsants
Psychomotor stimulants
Opioid antagonists
Opioid use disorder

Transcript

Watch video only

Barbiturates are a class of medications that are used as anticonvulsants to manage seizure disorders; to induce anesthesia in surgical procedures; as anxiolytics to relieve anxiety; and to manage insomnia. Barbiturates enhance the effect of gamma-aminobutyric acid, or GABA, which is the major inhibitory neurotransmitter in the brain, by binding to its receptor.

It’s pretty well-established that your brain’s really important. It controls your feelings, your movements, your sleep, your memory… It controls everything, whether you’re aware of it or not. The cells that make up our brain are called neurons. Neurons communicate with each other through neurotransmitters. When one neuron is stimulated, it’ll release excitatory neurotransmitters like glutamate, which bind to receptors on the next neuron. This causes the next neuron to depolarize and release its own excitatory neurotransmitters, propagating the signal throughout the brain.

Now, we also have inhibitory neurons that will shut down this chain of events. These neurons release the main inhibitory neurotransmitter in the nervous system, gamma-aminobutyric acid, or GABA, which binds to GABA receptors on other neurons. These receptors are large multi-unit complexes that form ligand-gated ion channels, which open up to let Cl- ions into the cell. The influx of negatively charged ions causes hyperpolarization, where the cell’s membrane potential becomes more negative, which means it’s much more difficult for it to depolarize and fire off an action potential, and that means it’s less responsive to stimuli.

Now, there are cases where neurons in the brain start sending out more excitatory signals than normal. This can occur due to either too much excitation by the excitatory neurotransmitters, or too little inhibition by the inhibitory neurotransmitters like GABA. Excessive excitatory signals can cause psychiatric disorders like anxiety, and neurological disorders like seizures and epilepsy.

Okay, so one way we can decrease the excitatory signals is by enhancing the effect of inhibitory neurons through medication like barbiturates. Common medications in this class include amobarbital, butabarbital, methohexital, PENTobarbital, PHENobarbital, and primidone, which is a prodrug of PHENobarbital. Another medication from this group is thiopental, but it’s not available in the U.S. and Canada anymore. These medications target the GABAA receptors but they bind at a different site than GABA or benzodiazepines. At lower doses, barbiturates enhance the effect of GABA by increasing the duration of Cl- channels opening, thereby increasing the influx of Cl- ions. As a result, high intracellular concentrations of Cl- ions cause membrane hyperpolarization, which means it’s much more difficult for the neuron to depolarize and fire off an action potential. This differentiates them from benzodiazepines which also work by binding to GABAA receptors, but in contrast to barbiturates, they work by increasing the frequency of Cl- channels opening. So remember, barbiDurates increase duration! At higher doses, these medications can mimic GABA effect by triggering the opening of these channels even without GABA. In addition, barbiturates block excitatory glutamate receptors called AMPA receptors and decrease neuronal excitability; but they also inhibit voltage-gated calcium channels and decrease the release of glutamate.

Now, let’s draw a chart of the dose-dependent effects of barbiturates. On the left side of the chart, let’s place central nervous effects; and on the bottom let’s place dose. Low doses of barbiturates cause sedation, disinhibition, and anxiolysis; but as the dose increases, barbiturates cause hypnosis, anesthesia, medullary depression, and eventually coma. 

Now at a higher dose, barbiturates also inhibit the electron transport chain, which is a process that occurs within the inner mitochondrial membrane and results in the synthesis of adenosine triphosphate, or ATP. ATP is the main form of energy that keeps all of our body cells going. So when the electron transport chain gets interrupted, the ATP synthesis doesn’t happen and that can eventually lead to the death of the cell. Barbiturates also induce a class of enzymes called cytochrome P450. These enzymes are involved in the metabolism of various medications like benzodiazepines, phenytoin, quinidine, warfarin, and others. Increased cytochrome P450 activity can cause these medications to break down more rapidly, so larger doses may be needed to achieve a therapeutic effect.  

Alright, now barbiturates are indicated when the neurons get “super excited” and we want to calm them down, like during an epileptic seizure where clusters of neurons in the brain become temporarily impaired and start firing off a ton of excitatory signals. Moreover, PHENobarbital is the first-line treatment for neonatal convulsions. Also, this feature makes them useful for treating acute anxiety states like a panic attack. In addition, barbiturates can be used for preoperative sedation and to induce anesthesia; but they can also be given as a hypnotic to induce sleep since we basically want to depress the function of the person’s nervous system. Finally, in life-threatening conditions, such as increased intracranial pressure, these medications can be used to decrease cerebral blood flow and induce coma, which is also known as the barbiturate-induced coma.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Does bright light have an anxiolytic effect? - an open trial" BMC Psychiatry (2007)
  5. "The use of phenobarbital and other anti-seizure drugs in newborns" Seminars in Fetal and Neonatal Medicine (2017)
  6. "Pediatric Epilepsy" Demos Medical Pub (2001)
  7. "Comparison of the effectiveness of phenobarbital, mephobarbital, primidone, diphenylhydantoin, ethotoin, metharbital, and methylphenylethylhydantoin in motor seizures" Clinical Pharmacology & Therapeutics (1962)